Human papillomavirus (HPV) has been identified as a causative agent of cervical cancer and oropharyngeal cancer (OPC). Intriguingly, estrogen and HPV were shown to play synergistic roles in cervical carcinogenesis. We recently demonstrated that the apolipoprotein B mRNA-editing catalytic polypeptide 3 (APOBEC3, A3) family, which is inducible by estrogen, could lead to HPV DNA hypermutation and cause viral DNA integration. In the present study, we examined the relationships between estrogen-estrogen receptor α (ERα) and A3s in HPV-positive OPC. ERα expression was associated with HPV positivity in OPC biopsy samples using immunohistochemical analysis and reverse-transcription quantitative polymerase chain reaction. In addition, ERα was significantly associated with improved overall survival in HPV-positive OPC (hazard ratio, 0.26; p = 0.029). APOBEC3A (A3A) mRNA was induced by estrogen in HPV and ERα-positive OPC cells. Furthermore, A3A mRNA and protein expression were significantly higher in ERα-positive cases than in ERα-negative ones, among HPV-positive biopsy samples (p = 0.037 and 0.047). These findings suggest that A3A is associated with a good prognosis in ERα-positive OPC, and indicate the prognostic significance of ERα in HPV-positive OPC. This is the first study to demonstrate the prognostic role of ERα in HPVpositive OPC.The two major carcinogenic causes of oropharyngeal cancer (OPC) are human papillomavirus (HPV) infection and exposure to tobacco and alcohol, which are defined as HPV-positive and HPV-negative OPCs, respectively. 1-3 There are many biological and clinical differences between HPV-positive and HPVnegative OPCs, including prognosis, involved subsites and degree of cellular differentiation. The incidence of HPV-positive OPC has been continuously increasing in developed countries, with 50-70% of OPCs found to be linked to HPV in the United States, Europe and Japan. 4,5 Therefore, a better understanding of the characteristics of HPV-positive OPC is needed.Cervical cancer is known for its association with HPV. Cervical epithelial cells infected by HPV undergo carcinogenic transformation through the development of cancer precursor lesions called atypical squamous metaplasia (ASM) and cervical intraepithelial neoplasia. However, only a small population of cervical epithelial cells infected by HPV can evolve into cervical cancers, 6 indicating that cervical cancer development potentially requires other contributing factors in addition to HPV. Based on the analysis of a cervical cancer model using transgenic mice expressing HPV oncogenes, estrogen was identified as one of such cofactors. 7,8 Another study reported that some cervical cancers expressed the aromatase enzyme